Latest Competition News

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Accent Resources NL has withdrawn a previously stated production target for its Magnetite Range Project, clarifying the figure was aspirational and non-compliant with ASX rules. The company continues to advance its flagship magnetite development in Western Australia, highlighting its alignment with green steel demand.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

HighCom Limited appoints seasoned executive Geoffrey Knox as Executive Chairman and CEO, signaling a strategic push to strengthen its defence manufacturing and sustainment operations in Australia and the US.

Magnum Mining and Exploration Limited has launched a $7 million capital raising via a placement of shares accompanied by 630 million new options exercisable at $0.015, set to expire in three years. The offer aims to bolster working capital and advance exploration projects across the US and Brazil.

Power Minerals has terminated its joint venture with Navigate Energy on the Rincon Lithium Project, opting to retain full ownership and seek new partners amid a buoyant lithium market.

Predictive Discovery has secured a crucial court approval for its acquisition of Robex Resources, paving the way for the deal to close in early 2026 pending final regulatory consents.

Racura Oncology has launched a strategic collaboration with Emory University to investigate (E,E)-bisantrene’s potential to overcome resistance to osimertinib in EGFR-mutated non-small cell lung cancer. This partnership aims to bolster Racura’s HARNESS-1 clinical trial and strengthen its position in the competitive lung cancer treatment landscape.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.